Dimensional Fund Advisors LP Sells 9,031 Shares of DENTSPLY SIRONA Inc (XRAY)

Share on StockTwits

Dimensional Fund Advisors LP trimmed its position in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 0.7% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,198,824 shares of the medical instruments supplier’s stock after selling 9,031 shares during the period. Dimensional Fund Advisors LP owned about 0.53% of DENTSPLY SIRONA worth $60,313,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. LPL Financial LLC increased its stake in shares of DENTSPLY SIRONA by 2.5% during the 4th quarter. LPL Financial LLC now owns 42,283 shares of the medical instruments supplier’s stock valued at $2,783,000 after acquiring an additional 1,024 shares during the last quarter. Teachers Advisors LLC increased its stake in shares of DENTSPLY SIRONA by 2.4% during the 4th quarter. Teachers Advisors LLC now owns 355,233 shares of the medical instruments supplier’s stock valued at $23,385,000 after acquiring an additional 8,227 shares during the last quarter. Schwab Charles Investment Management Inc. increased its stake in shares of DENTSPLY SIRONA by 4.4% during the 1st quarter. Schwab Charles Investment Management Inc. now owns 830,722 shares of the medical instruments supplier’s stock valued at $41,794,000 after acquiring an additional 35,359 shares during the last quarter. Raymond James Financial Services Advisors Inc. acquired a new position in shares of DENTSPLY SIRONA during the 4th quarter valued at about $315,000. Finally, The Manufacturers Life Insurance Company increased its stake in shares of DENTSPLY SIRONA by 27.4% during the 4th quarter. The Manufacturers Life Insurance Company now owns 317,402 shares of the medical instruments supplier’s stock valued at $20,893,000 after acquiring an additional 68,220 shares during the last quarter. Institutional investors own 93.80% of the company’s stock.

XRAY opened at $44.57 on Friday. The company has a market cap of $10.24 billion, a P/E ratio of 16.76, a price-to-earnings-growth ratio of 2.33 and a beta of 1.23. DENTSPLY SIRONA Inc has a 1 year low of $41.64 and a 1 year high of $68.98. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.23 and a quick ratio of 1.46.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Sunday, May 6th. The medical instruments supplier reported $0.45 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.42 by $0.03. The firm had revenue of $956.10 million during the quarter, compared to the consensus estimate of $942.20 million. DENTSPLY SIRONA had a negative net margin of 38.32% and a positive return on equity of 8.63%. The company’s revenue was up 6.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.49 EPS. analysts expect that DENTSPLY SIRONA Inc will post 2.57 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 13th. Investors of record on Friday, June 29th will be given a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a yield of 0.79%. The ex-dividend date is Thursday, June 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently 13.16%.

In related news, Director Michael J. Coleman sold 6,038 shares of the stock in a transaction that occurred on Friday, June 1st. The shares were sold at an average price of $43.97, for a total transaction of $265,490.86. Following the completion of the sale, the director now owns 26,960 shares of the company’s stock, valued at approximately $1,185,431.20. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Michael C. Alfano sold 1,404 shares of the stock in a transaction that occurred on Wednesday, May 30th. The stock was sold at an average price of $45.83, for a total transaction of $64,345.32. Following the sale, the director now directly owns 13,458 shares of the company’s stock, valued at approximately $616,780.14. The disclosure for this sale can be found here. In the last three months, insiders have sold 7,856 shares of company stock valued at $349,153. Corporate insiders own 1.93% of the company’s stock.

A number of research analysts have recently commented on the stock. Morgan Stanley dropped their price objective on shares of DENTSPLY SIRONA from $65.00 to $54.00 and set an “overweight” rating for the company in a research note on Thursday, June 14th. BidaskClub raised shares of DENTSPLY SIRONA from a “strong sell” rating to a “sell” rating in a research note on Wednesday, June 13th. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research note on Wednesday, June 6th. Northcoast Research downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a research note on Tuesday, June 5th. Finally, ValuEngine downgraded shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research note on Tuesday, May 22nd. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and nine have issued a buy rating to the stock. DENTSPLY SIRONA currently has an average rating of “Hold” and an average target price of $62.23.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply